Vineet R. Jindal
2021
In 2021, Vineet R. Jindal earned a total compensation of $2M as Chief Financial Officer at Reneo Pharmaceuticals.
Compensation breakdown
| Bonus | $150,000 |
|---|---|
| Non-Equity Incentive Plan | $121,400 |
| Option Awards | $1,417,830 |
| Salary | $296,875 |
| Total | $1,986,105 |
Jindal received $1.4M in option awards, accounting for 71% of the total pay in 2021.
Jindal also received $150K in bonus, $121.4K in non-equity incentive plan and $296.9K in salary.
Rankings
In 2021, Vineet R. Jindal's compensation ranked 6,069th out of 12,415 executives tracked by ExecPay. In other words, Jindal earned more than 51.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,069 out of 12,415 | 51st |
Division Manufacturing | 2,565 out of 5,508 | 53rd |
Major group Chemicals And Allied Products | 1,122 out of 2,378 | 53rd |
Industry group Drugs | 1,000 out of 2,099 | 52nd |
Industry Pharmaceutical Preparations | 722 out of 1,549 | 53rd |
Source: SEC filing on April 22, 2022.
Jindal's colleagues
We found two more compensation records of executives who worked with Vineet R. Jindal at Reneo Pharmaceuticals in 2021.